Valentina Parra1, Francisco Altamirano2, Carolina P Hernández-Fuentes2, Dan Tong2, Victoriia Kyrychenko2, David Rotter2, Zully Pedrozo2, Joseph A Hill2, Verónica Eisner2, Sergio Lavandero2, Jay W Schneider2, Beverly A Rothermel1. 1. From the Advanced Center for Chronic Diseases and Center for Molecular Studies of the Cell, Faculty of Chemical and Pharmaceutical Sciences and Faculty of Medicine (V.P., C.P.H.-F., Z.P., S.L.) and Institute of Biomedical Sciences, School of Medicine (Z.P.), University of Chile, Santiago; Department of Internal Medicine/Cardiology (V.P., F.A., D.T., V.K., D.R., Z.P., J.A.H., S.L., J.W.S., B.A.R.) and Department of Molecular Biology (V.K., J.A.H., B.A.R.), University of Texas Southwestern Medical Center, Dallas; and Department of Molecular and Cellular Biology, Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago (V.E.). beverly.rothermel@utsouthwestern.edu vparra@ciq.uchile.cl. 2. From the Advanced Center for Chronic Diseases and Center for Molecular Studies of the Cell, Faculty of Chemical and Pharmaceutical Sciences and Faculty of Medicine (V.P., C.P.H.-F., Z.P., S.L.) and Institute of Biomedical Sciences, School of Medicine (Z.P.), University of Chile, Santiago; Department of Internal Medicine/Cardiology (V.P., F.A., D.T., V.K., D.R., Z.P., J.A.H., S.L., J.W.S., B.A.R.) and Department of Molecular Biology (V.K., J.A.H., B.A.R.), University of Texas Southwestern Medical Center, Dallas; and Department of Molecular and Cellular Biology, Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago (V.E.).
Abstract
RATIONALE: The regulator of calcineurin 1 (RCAN1) inhibits CN (calcineurin), a Ca2+-activated protein phosphatase important in cardiac remodeling. In humans, RCAN1 is located on chromosome 21 in proximity to the Down syndrome critical region. The hearts and brains of Rcan1 KO mice are more susceptible to damage from ischemia/reperfusion (I/R); however, the underlying cause is not known. OBJECTIVE: Mitochondria are key mediators of I/R damage. The goal of these studies was to determine the impact of RCAN1 on mitochondrial dynamics and function. METHODS AND RESULTS: Using both neonatal and isolated adult cardiomyocytes, we show that, when RCAN1 is depleted, the mitochondrial network is more fragmented because of increased CN-dependent activation of the fission protein, DRP1 (dynamin-1-like). Mitochondria in RCAN1-depleted cardiomyocytes have reduced membrane potential, O2 consumption, and generation of reactive oxygen species, as well as a reduced capacity for mitochondrial Ca2+ uptake. RCAN1-depleted cardiomyocytes were more sensitive to I/R; however, pharmacological inhibition of CN, DRP1, or CAPN (calpains; Ca2+-activated proteases) restored protection, suggesting that in the absence of RCAN1, CAPN-mediated damage after I/R is greater because of a decrease in the capacity of mitochondria to buffer cytoplasmic Ca2+. Increasing RCAN1 levels by adenoviral infection was sufficient to enhance fusion and confer protection from I/R. To examine the impact of more modest, and biologically relevant, increases in RCAN1, we compared the mitochondrial network in induced pluripotent stem cells derived from individuals with Down syndrome to that of isogenic, disomic controls. Mitochondria were more fused, and O2 consumption was greater in the trisomic induced pluripotent stem cells; however, coupling efficiency and metabolic flexibility were compromised compared with disomic induced pluripotent stem cells. Depletion of RCAN1 from trisomic induced pluripotent stem cells was sufficient to normalize mitochondrial dynamics and function. CONCLUSIONS: RCAN1 helps maintain a more interconnected mitochondrial network, and maintaining appropriate RCAN1 levels is important to human health and disease.
RATIONALE: The regulator of calcineurin 1 (RCAN1) inhibits CN (calcineurin), a Ca2+-activated protein phosphatase important in cardiac remodeling. In humans, RCAN1 is located on chromosome 21 in proximity to the Down syndrome critical region. The hearts and brains of Rcan1 KO mice are more susceptible to damage from ischemia/reperfusion (I/R); however, the underlying cause is not known. OBJECTIVE: Mitochondria are key mediators of I/R damage. The goal of these studies was to determine the impact of RCAN1 on mitochondrial dynamics and function. METHODS AND RESULTS: Using both neonatal and isolated adult cardiomyocytes, we show that, when RCAN1 is depleted, the mitochondrial network is more fragmented because of increased CN-dependent activation of the fission protein, DRP1 (dynamin-1-like). Mitochondria in RCAN1-depleted cardiomyocytes have reduced membrane potential, O2 consumption, and generation of reactive oxygen species, as well as a reduced capacity for mitochondrial Ca2+ uptake. RCAN1-depleted cardiomyocytes were more sensitive to I/R; however, pharmacological inhibition of CN, DRP1, or CAPN (calpains; Ca2+-activated proteases) restored protection, suggesting that in the absence of RCAN1, CAPN-mediated damage after I/R is greater because of a decrease in the capacity of mitochondria to buffer cytoplasmic Ca2+. Increasing RCAN1 levels by adenoviral infection was sufficient to enhance fusion and confer protection from I/R. To examine the impact of more modest, and biologically relevant, increases in RCAN1, we compared the mitochondrial network in induced pluripotent stem cells derived from individuals with Down syndrome to that of isogenic, disomic controls. Mitochondria were more fused, and O2 consumption was greater in the trisomic induced pluripotent stem cells; however, coupling efficiency and metabolic flexibility were compromised compared with disomic induced pluripotent stem cells. Depletion of RCAN1 from trisomic induced pluripotent stem cells was sufficient to normalize mitochondrial dynamics and function. CONCLUSIONS:RCAN1 helps maintain a more interconnected mitochondrial network, and maintaining appropriate RCAN1 levels is important to human health and disease.
Authors: Fabio Di Lisa; Marcella Canton; Andrea Carpi; Nina Kaludercic; Roberta Menabò; Sara Menazza; Martina Semenzato Journal: Antioxid Redox Signal Date: 2010-11-30 Impact factor: 8.401
Authors: J J Fuentes; L Genescà; T J Kingsbury; K W Cunningham; M Pérez-Riba; X Estivill; S de la Luna Journal: Hum Mol Genet Date: 2000-07-01 Impact factor: 6.150
Authors: Alexis Diaz-Vegas; Pablo Sanchez-Aguilera; James R Krycer; Pablo E Morales; Matías Monsalves-Alvarez; Mariana Cifuentes; Beverly A Rothermel; Sergio Lavandero Journal: Endocr Rev Date: 2020-06-01 Impact factor: 19.871
Authors: Carolin Lerchenmüller; Ana Vujic; Anthony Rosenzweig; Richard T Lee; Sonja Mittag; Annie Wang; Charles P Rabolli; Chiara Heß; Fynn Betge; Ashraf Y Rangrez; Malay Chaklader; Christelle Guillermier; Frank Gyngard; Jason D Roh; Haobo Li; Matthew L Steinhauser; Norbert Frey; Beverly Rothermel; Christoph Dieterich Journal: Circulation Date: 2022-07-06 Impact factor: 39.918
Authors: Sandra Espinoza; Felipe Grunenwald; Wileidy Gomez; Felipe García; Lorena Abarzúa-Catalan; Sebastián Oyarce-Pezoa; Maria Fernanda Hernandez; Bastián I Cortés; Markus Uhrig; Daniela P Ponce; Claudia Durán-Aniotz; Claudio Hetz; Carol D SanMartín; Victor H Cornejo; Fernando Ezquer; Valentina Parra; Maria Isabel Behrens; Patricio A Manque; Diego Rojas-Rivera; René L Vidal; Ute Woehlbier; Melissa Nassif Journal: Cells Date: 2022-06-07 Impact factor: 7.666
Authors: David Rotter; Heshan Peiris; D Bennett Grinsfelder; Alyce M Martin; Jana Burchfield; Valentina Parra; Christi Hull; Cyndi R Morales; Claire F Jessup; Dusan Matusica; Brian W Parks; Aldons J Lusis; Ngoc Uyen Nhi Nguyen; Misook Oh; Israel Iyoke; Tanvi Jakkampudi; D Randy McMillan; Hesham A Sadek; Matthew J Watt; Rana K Gupta; Melanie A Pritchard; Damien J Keating; Beverly A Rothermel Journal: EMBO Rep Date: 2018-11-02 Impact factor: 8.807
Authors: Mara Dierssen; Yann Herault; Pablo Helguera; Maria Martínez de Lagran; Anna Vazquez; Bradley Christian; Maria Carmona-Iragui; Frances Wiseman; William Mobley; Elizabeth M C Fisher; Veronique Brault; Anna Esbensen; Lisa M Jacola; Marie Claude Potier; Eric D Hamlett; Leonard Abbeduto; Laura Del Hoyo Soriano; Jorge Busciglio; Maria Florencia Iulita; John Crispino; Sébastien Malinge; Eugenio Barone; Marzia Perluigi; Floriana Costanzo; Jean Maurice Delabar; Renata Bartesaghi; Alain D Dekker; Peter De Deyn; Juan Fortea Ormaechea; Patricia A Shaw; Tarik F Haydar; Stephanie L Sherman; André Strydom; Anita Bhattacharyya Journal: Mol Syndromol Date: 2021-05-20
Authors: Dan Tong; Gabriele G Schiattarella; Nan Jiang; Francisco Altamirano; Pamela A Szweda; Abdallah Elnwasany; Dong I Lee; Heesoo Yoo; David A Kass; Luke I Szweda; Sergio Lavandero; Eric Verdin; Thomas G Gillette; Joseph A Hill Journal: Circ Res Date: 2021-04-22 Impact factor: 23.213
Authors: Silvia Villahoz; Paula Sofía Yunes-Leites; Nerea Méndez-Barbero; Katia Urso; Elena Bonzon-Kulichenko; Sagrario Ortega; J Francisco Nistal; Jesus Vazquez; Stefan Offermanns; Juan Miguel Redondo; Miguel R Campanero Journal: Nat Commun Date: 2018-11-15 Impact factor: 14.919
Authors: Soo Young Kim; Xin Zhang; Gabriele G Schiattarella; Francisco Altamirano; Thais A R Ramos; Kristin M French; Nan Jiang; Pamela A Szweda; Bret M Evers; Herman I May; Xiang Luo; Hongliang Li; Luke I Szweda; Vinicius Maracaja-Coutinho; Sergio Lavandero; Thomas G Gillette; Joseph A Hill Journal: Circulation Date: 2020-10-28 Impact factor: 39.918